Acadian Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-883
Closed -$38K 1864
2023
Q3
$38K Buy
883
+386
+78% +$16.6K ﹤0.01% 1460
2023
Q2
$17K Buy
+497
New +$17K ﹤0.01% 1658
2023
Q1
Sell
-2,300
Closed -$102K 2027
2022
Q4
$102K Buy
+2,300
New +$102K ﹤0.01% 1427
2022
Q3
Sell
-10,448
Closed -$701K 1903
2022
Q2
$701K Buy
10,448
+8,124
+350% +$545K ﹤0.01% 892
2022
Q1
$189K Buy
+2,324
New +$189K ﹤0.01% 1228
2018
Q2
Sell
-547
Closed -$17K 1887
2018
Q1
$17K Buy
+547
New +$17K ﹤0.01% 1508